Peptides having insulin autoantibody but not insulin receptor binding capacity
US5422339A · kind A · utility
14Cited by
0References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 14, 1994 |
| Grant date | Jun 6, 1995 |
| Priority date | — |
| Expiry date | Mar 14, 2014 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A therapeutic agent that includes a purified peptide bound to a cytotoxic moiety, the peptide being specifically reactive with human insulin autoantibodies and non-reactive with human insulin cell surface receptor, is disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.